Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results


2014 | 12 | 10 | 1047-1055

Article title

Synthesis and antiproliferative activity in vitro of new 2-aminobenzimidazole derivatives. Reaction of 2-arylideneaminobenzimidazole with selected nitriles containing active methylene group


Title variants

Languages of publication



A series of pyrimido[1,2-a]benzimidazole and α-cyanocinnamic acid derivatives have been synthesized in the reactions of Schiff bases 2–7 with selected nitriles containing an active methylene group: malononitrile 8–12, cyanoacetamide 13–16, benzyl cyanide 17–21, benzoylacetonitrile 22–24, cyanoacetate methyl ester 25–28 and benzylacetamide 29. The structures 8–29 were confirmed by the results of elementary analysis and their IR, 1H-, 13C-NMR and MS spectra. The products 8–29 of various chemical structure pyrimido[1,2-a] benzimidazole 8–12, 14–16, 17–21, 23–24, 26 and α-cyanocinnamic acid derivatives 13, 22, 25, 27, 28 were obtained, which are of interest for biological studies or which can be substrates for further synthesis. The selected compounds 10, 13, 14, 17, 19, 21, 23–25 and 28 were screened for their antiproliferative activity in vitro against neoplastic and normal cell lines. The most active two compounds were: 2-(o-bromophenylene)-3-cyano-4-phenyl-1,2-dihydropyrimido[1,2-a]benzimidazole (24) and 3-cyano-4-phenyl-2-(2,4-dimethoxyphenyl)-1,2-dihydropyrimido[1,2-a]benzimidazole (23). However, similarly like cisplatin used as the control, they showed no selectivity towards cancer cells, by inhibiting proliferation of normal mouse fibroblasts in similar manner.










Physical description


1 - 10 - 2014
15 - 5 - 2014


  • Wroclaw Medical University
  • Wroclaw Medical University
  • Wroclaw Medical University
  • Polish Academy of Science
  • Polish Academy of Science
  • Wroclaw Medical University


  • [1] The Merck Index, 14th edition (Whitehouse Station, USA, 2006)
  • [2] V.A. Anisimova, M.M. Osipova, A.A. Spasov, A.F. Turchaeva, G.P. Dudchenko, N.P. Larionov, S.G. Kovalcv, Pharm. Chem. J. 36, 468 (2002) http://dx.doi.org/10.1023/A:1021888520874[Crossref]
  • [3] A. Settimo, G. Primofiore, F. Settimo, A.M. Marini, Il Farmaco 47, 1293 (1992)
  • [4] J.P. Powers, S. Li, J.C. Jaen, J. Liu, N.P.C. Walker, Z. Wang, H. Wesche, Bioorg. Med. Chem. Lett. 16, 2842 (2006) http://dx.doi.org/10.1016/j.bmcl.2006.03.020[Crossref]
  • [5] P.F. Asobo, H. Wahe, J.T. Mbafor, A.E. Nkengfack, Z.T. Fomum, E.F. Sophue, D. Döpp, J. Chem. Soc. Perkin Trans. 1, 457 (2001) http://dx.doi.org/10.1039/b005511p[Crossref]
  • [6] J. Madden, J.R. Dod, R. Godemann, J. Kraemer, M. Smith, M. Biniszkiewicz, D.J. Hallett, J. Barker, J.D. Dyekjaer, T. Hesterkamp, Bioorg. Med. Chem. Lett. 20, 5329 (2010) http://dx.doi.org/10.1016/j.bmcl.2010.06.089[Crossref]
  • [7] P.P. Seth, E.A. Jefferson, L.M. Risen, S.A. Osgood, Bioorg.Med. Chem. 13, 1669 (2003) http://dx.doi.org/10.1016/S0960-894X(03)00245-2[Crossref]
  • [8] S.O. Podunavac-Kuzmanović, D.D. Cvetkovic, CI&CEQ 17, 9 (2011) http://dx.doi.org/10.2298/CICEQ100329044P[Crossref]
  • [9] T.A. Farghaly, N.A.A. Hafez, E.A. Ragab, H.M. Awad, M.M. Abdalla, Eur. J. Med. Chem. 45, 492 (2010) http://dx.doi.org/10.1016/j.ejmech.2009.10.033[Crossref]
  • [10] W.P. Nawrocka, Boll. Chim. Farm. 135, 18 (1996)
  • [11] W.P. Nawrocka, A. Nowicka, H. Liszkiewicz, Wiad. Chem. 66, 811 (2012) (in Polish)
  • [12] W.P. Nawrocka, A. Nowicka, H. Liszkiewicz, Wiad. Chem. 66, 839 (2012) (in Polish)
  • [13] W.P. Nawrocka, A. Nowicka, Wiad. Chem. 67, 715 (2013) (in Polish)
  • [14] A. Nowicka, W.P. Nawrocka, Wiad. Chem. 67, 695 (2013) (in Polish)
  • [15] A. Nowicka, W.P. Nawrocka, Wiad. Chem. 67, 203 (2013) (in Polish)
  • [16] W.P. Nawrocka, B. Sztuba, A. Dryś, J. Wietrzyk, J. Kosendiak, A. Opolski, Pol.J.Chem., 80, 279 (2006)
  • [17] W.P. Nawrocka, M.W. Kowalska, B. Sztuba, A. Dryś, J. Wietrzyk, B. Filip, Pol. J. Chem. 81, 1753 (2007)
  • [18] W.P. Nawrocka, B. Sztuba, M.W. Kowalska, H. Liszkiewicz, J. Wietrzyk, A. Nasulewicz, M. Pełczyńska, A. Opolski, Il Farmaco 59, 83 (2004) http://dx.doi.org/10.1016/j.farmac.2003.12.001[Crossref]
  • [19] M. Rai, S. Kumar, K. Krishan, A. Singh, Indian J. Chem. 17B, 287 (1979)
  • [20] M. Rai, K. Krishan, A. Singh, Indian J. Chem. 13, 991 (1975)
  • [21] F.A. Bassyouni, I.I. Ismail, Afinidad LVIII, 375, (2001)
  • [22] M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery, Jr., T. Vreven, K.N. Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. Al-Laham, C.Y. Peng, A. Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, J.A. Pople, Gaussian 03, Revision C.02 (Gaussian, Inc., Wallingford, CT, 2004)
  • [23] J. Wietrzyk, M. Chodynski, H. Fitak, E. Wojdat, A. Kutner, A. Opolski, Anticancer Drugs 18, 447 (2007) http://dx.doi.org/10.1097/CAD.0b013e3280143166[Crossref]

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.